Mekonos, Inc., a biotech platform company building the future of cell engineering on a chip, announced it has entered into a partnership agreement with...
Velsera, a pioneering entity in the field of computational biology with a focus on advancing precision medicine, is delighted to formally announce the appointment...
Have you ever questioned why some people experience great results from a particular drug but not others? Our genes contain the solution. That's accurate;...
Tempus, a leader in artificial intelligence and precision medicine, announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device...
Athos Therapeutics, Inc. ("Athos"), a late-stage preclinical biotech company using artificial intelligence to develop small molecule therapeutics for immune-mediated diseases and cancer, announced a...
